Bio Essence Corporation
BIOE
$0.18
-$0.07-27.96%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 500.50K | 1.48M | 136.80K | 259.10K | 22.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 500.50K | 1.48M | 136.80K | 259.10K | 22.20K |
| Cost of Revenue | 181.20K | 336.00K | 41.00K | 90.50K | 1.60K |
| Gross Profit | 319.40K | 1.14M | 95.80K | 168.60K | 20.60K |
| SG&A Expenses | 103.60K | 113.80K | 81.50K | 107.40K | 225.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 284.70K | 449.80K | 122.50K | 197.90K | 227.30K |
| Operating Income | 215.80K | 1.03M | 14.30K | 61.20K | -205.10K |
| Income Before Tax | 215.20K | 1.03M | 13.00K | 60.70K | -205.80K |
| Income Tax Expenses | 9.80K | 0.00 | -- | 800.00 | -- |
| Earnings from Continuing Operations | 205.40K | 1.03M | 13.00K | 59.90K | -205.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 205.40K | 1.03M | 13.00K | 59.90K | -205.80K |
| EBIT | 215.80K | 1.03M | 14.30K | 61.20K | -205.10K |
| EBITDA | 215.90K | 1.03M | 14.30K | 61.30K | -205.00K |
| EPS Basic | 0.00 | 0.03 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.05 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 44.95M | 38.01M | 38.01M | 38.01M | 38.01M |
| Average Diluted Shares Outstanding | 44.95M | 38.01M | 38.01M | 38.01M | 38.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |